Compounds > galantamine

galantamine and Action Tremor

galantamine has been researched along with Action Tremor in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baqi, Y; Collins-Praino, LE; Kovner, R; Ledgard, F; Müller, CE; Paul, NE; Podurgiel, SJ; Salamone, JD; Senatus, PB1
Baqi, Y; Correa, M; Kovner, R; Müller, CE; Podurgiel, SJ; Salamone, JD; Spencer, T1
Aw, CC; Browne, ER; Chen, CP; Goh, CW; Lee, JH1
Abbas, SF; Baqi, Y; Chrobak, JJ; Collins, LE; Galtieri, DJ; Leser, CE; Müller, CE; Paul, NE; Podurgiel, SJ; Salamone, JD1
Erkova, AI; Savateev, NV; Sherstobitov, OE; Sofronov, GA1

Other Studies

6 other study(ies) available for galantamine and Action Tremor

ArticleYear
Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism.
    The European journal of neuroscience, 2013, Volume: 38, Issue:1

    Topics: Adenosine A2 Receptor Antagonists; Animals; Deep Brain Stimulation; Disease Models, Animal; Dopamine Antagonists; Galantamine; Jaw; Male; Movement; Parkinson Disease, Secondary; Pilocarpine; Rats; Rats, Sprague-Dawley; Subthalamic Nucleus; Tremor; Xanthines

2013
Induction of oral tremor in mice by the acetylcholinesterase inhibitor galantamine: Reversal with adenosine A2A antagonism.
    Pharmacology, biochemistry, and behavior, 2016, Volume: 140

    Topics: Adenosine A2 Receptor Antagonists; Animals; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Galantamine; Jaw; Male; Mice; Mice, Inbred C57BL; Movement; Parkinson Disease, Secondary; Receptor, Adenosine A2A; Tremor; Xanthines

2016
Pharmacokinetic and pharmacodynamic properties of cholinesterase inhibitors donepezil, tacrine, and galantamine in aged and young Lister hooded rats.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:3

    Topics: Aging; Animals; Biological Availability; Brain; Cholinesterase Inhibitors; Cholinesterases; Donepezil; Dose-Response Relationship, Drug; Galantamine; Half-Life; Hypothermia; Indans; Male; Metabolic Clearance Rate; Piperidines; Random Allocation; Rats; Rats, Inbred Strains; Receptor, Muscarinic M2; Salivation; Tacrine; Tears; Tremor

2011
Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease.
    Pharmacology, biochemistry, and behavior, 2011, Volume: 99, Issue:3

    Topics: Alzheimer Disease; Animals; Cholinergic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Electromyography; Galantamine; Jaw; Male; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Treatment Outcome; Tremor

2011
Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
    Prescrire international, 2007, Volume: 16, Issue:91

    Topics: Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Dystonia; France; Galantamine; Humans; Indans; Lewy Body Disease; Parkinson Disease; Phenylcarbamates; Piperidines; Tremor

2007
[Some differences in the effects of anticholinesterase compounds on nicotine and arecoline sensitivity in mice and rabbits].
    Doklady Akademii nauk SSSR, 1966, Apr-11, Volume: 167, Issue:5

    Topics: Animals; Bradycardia; Central Nervous System; Cholinesterase Inhibitors; Galantamine; Heart; Mice; Nicotine; Parasympathomimetics; Peripheral Nerves; Phosphates; Rabbits; Tremor

1966